Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme ; volume:9 ; number:1 ; day:16 ; month:12 ; year:2009 ; pages:1-9 ; date:12.2009
BMC cancer ; 9, Heft 1 (16.12.2009), 1-9, 12.2009
- Urheber
-
Verhoeff, Joost JC
- Beteiligte Personen und Organisationen
-
van Tellingen, Olaf
Claes, An
Stalpers, Lukas JA
van Linde, Myra E.
Richel, Dirk J.
Leenders, William PJ
van Furth, Wouter R.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-9-444
- URN
-
urn:nbn:de:1111-2016030354414
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Verhoeff, Joost JC
- van Tellingen, Olaf
- Claes, An
- Stalpers, Lukas JA
- van Linde, Myra E.
- Richel, Dirk J.
- Leenders, William PJ
- van Furth, Wouter R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Characterization of anti-angiogenic therapy response in glioblastoma
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Tenascin-C orchestrates glioblastoma angiogenesis by modulation of pro- and anti-angiogenic signaling
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Contemporary updates on clinical trials of antiangiogenic agents in the treatment of glioblastoma multiforme
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy
Glioblastoma multiforme-das Schicksal
Bilateral cystic glioblastoma multiforme
Prognosefaktoren beim Glioblastoma multiforme
Characterization of anti-angiogenic therapy response in glioblastoma
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Tenascin-C orchestrates glioblastoma angiogenesis by modulation of pro- and anti-angiogenic signaling
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Contemporary updates on clinical trials of antiangiogenic agents in the treatment of glioblastoma multiforme
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy
Glioblastoma multiforme-das Schicksal
Bilateral cystic glioblastoma multiforme
Prognosefaktoren beim Glioblastoma multiforme
Characterization of anti-angiogenic therapy response in glioblastoma
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Tenascin-C orchestrates glioblastoma angiogenesis by modulation of pro- and anti-angiogenic signaling
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Contemporary updates on clinical trials of antiangiogenic agents in the treatment of glioblastoma multiforme
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy
Glioblastoma multiforme-das Schicksal
Bilateral cystic glioblastoma multiforme